Erlene Seymour

Flatiron Health, United States

Flatiron Health (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)

Presentation(s):

• Comparison of Denosumab versus Bisphosphonates on Progression-free and Overall Survival in Newly Diagnosed Multiple Myeloma: A New User, Active Comparator Analysis of Real-World Data

  Sunday, August 28, 2022
  2:15 PM – 2:30 PM CEST